📝 Natural Biocon (India) Ltd — results explained
Quarter ended March 2026 (Q4 FY26)
Natural Biocon (India) Ltd reported revenue of ₹1 crore for the quarter ended March 2026 (Q4 FY26), down 34.8% from ₹1 crore in the same quarter last year.
The company reported a net loss of ₹0 crore, against a net loss of ₹0 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.03.
Operating profit stood at ₹-0 crore — an operating margin (OPM) of -10.2%, compared with -36.3% in the year-ago quarter.
Full year and trailing twelve months
For the full year FY26, Natural Biocon (India) Ltd posted revenue of ₹3 crore, a decline of 69.5% over FY25, with a net loss of ₹0 crore.
On a trailing-twelve-month (TTM) basis, revenue stands at ₹3 crore with a net loss of ₹0 crore.
Valuation snapshot
At the current price of ₹3.36, 543207 has a market capitalisation of ₹9 crore.
Within the Pesticides & Agrochemicals industry, it is the 8th-largest of the 9 companies we track by market value.
Shareholding pattern
As of Mar 2026, promoters held 9.36%, public shareholders 90.64% of Natural Biocon (India) Ltd.